<DOC>
	<DOCNO>NCT01366573</DOCNO>
	<brief_summary>The aim study assess safety tolerability GSK1521498 combination alcohol determine amount GSK1521498 alcohol blood give together . The study also determine whether GSK1521498 effect alcohol like consumption .</brief_summary>
	<brief_title>GSK1521498 Alcohol Interaction Study</brief_title>
	<detailed_description>The study test new drug may use treat alcohol addiction . The drug work inhibit effect messenger molecule call opioids . These opioids naturally produce within human body , involve control much alcohol drink pleasure get drinking alcohol . We believe GSK1521498 might effective treatment alcohol addiction well know drug work similar binding site brain reduce pleasure get drinking alcohol . As alcohol effect way drug metabolise body , The investigator need determine safe take GSK1521498 combination alcohol . determine amount GSK1521498 alcohol blood give together . The study also determine whether GSK1521498 effect alcohol like consumption .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>healthy male female 21 55 year age inclusive . within 20 % normal weight height body build . A female subject childbearing potential must use one contraception method list protocol prior start study least 14 day receive last dose study medication . Male subject must agree use one contraception method list protocol time first dose study medication least 5 day receive last dose study medication . History regular alcohol consumption within 6 month study . No recent change pattern alcohol consumption . Capable give write informed consent , include compliance requirement restriction list consent form . A positive test HIV , Hep B Hep C. Current chronic history liver disease . Current chronic history neurological disorder . Subjects previous current psychiatric history . Past history DSMIV alcohol dependence abuse . Binge drink week ( &gt; 5 standard drink one session binge ) . Currently try quit alcohol . Positive urine screen amphetamine , barbiturate , cocaine , opiates , cannabinoids bezodiazepines screen . Regular consumption &gt; 450mg caffeine per day ( average cup contain 75mg ) . Heavy smoker , define smoke &gt; 10 cigarette day . Also abstain admission period . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 14 day prior first dose study medication . Pregnant lactating female . QTcB QTcF &gt; 450msec . Participated clinical trial receive investigational product within 30 day , 5 halflives twice duration biological effect investigational product . Where participation study would result donation blood blood product excess 500mL within 56 day period .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>mu-opioid receptor</keyword>
	<keyword>Addiction</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Alcohol</keyword>
</DOC>